Foundation Consumer Healthcare, a portfolio company of Kelso & Company and Juggernaut Capital Partners, has agreed to sell a portfolio of over-the-counter consumer health brands, including Breathe Right, to publicly traded Prestige Consumer Healthcare at an enterprise value of $1.045 billion.
Pittsburgh-headquartered Foundation Consumer Healthcare (FCH) develops and markets a portfolio of over-the-counter respiratory, pediatric, and oral care medicines. The divested assets include Breathe...
Continue Reading
Sign up for FREE to read the full article and access 132K+ alternative investment headlines.